# A Study to Investigate Delayed-release Tablets

> **NCT02004301** · PHASE1 · COMPLETED · sponsor: **BDD Pharma Ltd** · enrollment: 12 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** Radiolabelled T4 Tablet
- **DRUG:** Radiolabelled T6 Tablet

## Key facts

- **NCT ID:** NCT02004301
- **Lead sponsor:** BDD Pharma Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2014-03
- **Final completion:** 2014-03
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2014-04-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02004301

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02004301, "A Study to Investigate Delayed-release Tablets". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02004301. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
